---
title: EU MDR Regulations
---

# EU MDR Regulations

## Primary Legislation

| Document | OJ Reference | Date | Status |
|----------|-------------|------|--------|
| [EU MDR 2017/745](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0745) | OJ L 117, 5.5.2017 | 2017 | In force |
| [EU IVDR 2017/746](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0746) | OJ L 117, 5.5.2017 | 2017 | In force |
| [Amendment 2020/561](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32020R0561) | OJ L 130, 24.4.2020 | 2020 | MDR transition extension |
| [Amendment 2023/607](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32023R0607) | OJ L 80, 20.3.2023 | 2023 | Legacy device transition |
| [Amendment 2024/1860](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32024R1860) | OJ L, Jul 2024 | 2024 | Further transition extension |

## Implementation Timeline

| Date | Milestone |
|------|-----------|
| 26 May 2021 | EU MDR 2017/745 fully applicable |
| 26 May 2024 | Class IIb implantable legacy devices deadline |
| 31 Dec 2027 | Class IIb non-implantable + Class IIa legacy devices deadline |
| 31 Dec 2028 | Class I legacy devices deadline |
| 26 May 2022 | EU IVDR 2017/746 fully applicable (Class D IVDs) |
| 26 May 2025 | Class C IVDs deadline |
| 26 May 2026 | Class B + Class A sterile IVDs deadline |

## Key Articles

### Article 10 — General Obligations of Manufacturers
Manufacturers must:
- Establish, document, implement and maintain a **Quality Management System (QMS)**
- Conduct **clinical evaluation** in accordance with Annex XIV
- Establish a **post-market surveillance (PMS)** system per Annex III
- Register in **EUDAMED** and assign a **UDI**
- Designate an **Authorized Representative** (if outside EU)
- Appoint a **Person Responsible for Regulatory Compliance (PRRC)**

### Article 52 — Conformity Assessment Procedures

| Device Class | Procedure |
|-------------|----------|
| Class I (non-sterile, non-measuring) | Self-declaration (Annex IV) |
| Class I sterile / measuring | QMS (Annex IX) or Type Examination (Annex X) + Verification (Annex XI) |
| Class IIa | QMS (Annex IX) or Type Examination (Annex X) + Verification (Annex XI) |
| Class IIb | QMS (Annex IX) or Type Examination (Annex X) + Verification (Annex XI) |
| Class III | QMS (Annex IX) + Design Dossier, or Type Examination (Annex X) + Conformity (Annex XI) |

### Annex I — General Safety and Performance Requirements (GSPR)

Annex I contains requirements across 3 parts:

**Part I — General Requirements (GSPR 1–9)**
- GSPR 1: Devices shall achieve intended purpose, not compromise safety
- GSPR 2: Risk management — reduce risks as far as possible (ALARP)
- GSPR 3: Known and foreseeable risks minimized
- GSPR 6: Benefits shall outweigh risks

**Part II — Requirements for Design and Manufacture (GSPR 10–22)**
- GSPR 10: Chemical, physical, biological properties
- GSPR 11: Infection and microbial contamination
- GSPR 17: Electronic programmable systems — software
- GSPR 18: Active devices and devices connected to them

**Part III — Requirements for Information Supplied with the Device (GSPR 23)**
- GSPR 23: Label and instructions for use requirements

## Quality Management

- **ISO 13485:2016** — Medical devices QMS (harmonised under EU MDR)
- **EN ISO 13485:2016** — European adoption

## Related Legislation

| Regulation | Topic |
|------------|-------|
| [Regulation (EU) 2022/123](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32022R0123) | EUDAMED and Notified Bodies |
| [Directive 2006/42/EC](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32006L0042) | Machinery Directive |
| [Regulation (EU) 2016/679](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32016R0679) | GDPR (data protection) |

::: tip
Full regulation texts at [EUR-Lex](https://eur-lex.europa.eu). Source files in [eu_mdr/regulations/](https://github.com/RASAAS/docmcp-knowledge/tree/main/eu_mdr/regulations).
:::
